arrow
B

Bryson W. Katona

New York University
H指数:32
被引数:4,271

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A randomized study of digital versus genetic counselor return of actionable genetic research results to biobank participants (RESPECT3 study)

一项关于将可操作的遗传研究结果(通过数字方式与遗传咨询师)返还给生物样本库参与者的随机研究(RESPECT3研究)

2026-03-310
OAAI
An electronic review of clinical outcomes after return of actionable genetic research results from a health system research biobank

基于健康系统研究生物库可操作遗传研究结果返回后的临床结局电子回顾研究

2025-11-010
OAAI
Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma

血清基生物标志物特征在早期胰腺导管腺癌检测中的验证

2025-10-270
OAAI
High Performance of a Blood-Based Biomarker Test to Detect Early-Stage Pancreatic Cancer in a High-Risk Population, Across 2 Independent Clinical Validation Studies

一项血液生物标志物检测在两项独立临床验证研究中,对高风险人群中早期胰腺癌的高性能检测。

2025-10-010
PRE
354a: ONGOING PHASE 1B/2 TRIAL OF THE ALLOSTERIC MEK1/2 INHIBITOR REC-4881 AS MONOTHERAPY IN FAMILIAL ADENOMATOUS POLYPOSIS (FAP): PRELIMINARY SAFETY AND EFFICACY DATA

354a: REC-4881作为选择性MEK1/2变构抑制剂的单药治疗在家族性腺瘤性息肉病(FAP)中的Ib/II期临床试验:初步安全性和有效性数据

2025-07-030
PRE
Microbiota and metabolite-based prediction tool for colonic polyposis with and without a known genetic driver

基于微生物群和代谢物的结肠息肉(已知和未知遗传驱动因素)的预测工具

2025-03-111
OA
Genetic/Familial High-Risk Assessment: Colorectal,Endometrial, and Gastric, Version 3.2024

遗传/家族高危评估:结直肠、子宫内膜和胃,版本 3.2024

2024-12-015
PRE
The incidence of pancreatic cancer in women with a BRCA1 or BRCA2 mutation

BRCA1或BRCA2突变女性的胰腺癌发病率

CANCER
IF5.1
2024-11-290
PRE
Facilitating return of actionable genetic research results from a biobank repository: Participant uptake and utilization of digital interventions
2024-10-010
OAAI